The five-year survival rate for non-Hodgkin’s lymphoma ranges from 26% to 73%.
Non-Hodgkin’s lymphoma is a type of lymphoma with complex and varied main symptoms and slow growth, which can be classified into inert lymphoma and aggressive lymphoma.
The prognosis of different types of non-Hodgkin’s lymphoma varies, and the more malignant the tumor is, the worse the prognosis is. Its prognosis is also closely related to high-risk factors, and its risk factors include age over 60 years, stage III or stage IV tumors, more than one site of extra-lymphatic lymph node invasion, needing to be bed-ridden or cared for, and a significant elevation of serum LDH.
Low-risk patients with 0 to 1 risk factor have a five-year survival rate of 73%, intermediate-risk patients with 2 risk factors have a five-year survival rate of 50%, high-intermediate-risk patients with 3 risk factors have a five-year survival rate of 43%, and high-risk patients with 4 to 5 risk factors have a five-year survival rate of only 26%.
Non-Hodgkin’s lymphoma, if diagnosed, is recommended to be treated as soon as possible under the guidance of a physician for the best prognosis.